http://www.fpnotebook.com/
Acetylsalicylic acid
Aka: Acetylsalicylic acid, Aspirin, ASA
- See Also
- Salicylate
- Salicylate Toxicity
- Indications
- Prevention of coronary and cerebrovascular events
- Analgesia in rheumatic conditions
- Contraindications
- Children with viral illness (Varicella, Influenza)
- Risk of Reye's Syndrome (FDA Black Box Warning)
- Gout
- Hypersensitivity to Aspirin
- Active Peptic Ulcer Disease
- History
- Willow bark contains Salicin (Salicylic acid)
- Used in folk medicine for mild pain and fever
- Acetylsalicylic acid is a derivative of salicylic acid
- Synthesized in 1853 by the Bayer brothers
- Mechanism
- Antiinflammatory effect
- Inhibits prostaglandin biosynthesis
- Analgesic effect
- Relieves pain of mild to moderate intensity
- Antipyretic (Lowers temperature)
- Platelet Effects
- Inhibits Thromboxane synthesis
- Inhibits platelet aggregation
- Effects last 8 days (until new platelets)
- Dosing
- Use lowest appropriate dose (reduces adverse effects)
- Anticoagulation (Anti-Platelet action)
- General
- Do not exceed 160 mg qd if on Coumadin
- Acute Myocardial Infarction
- Primary prevention: 81 mg PO qd
- Immediate Myocardial Infarction Management: 325 mg
- Tertiary prevention (post-MI): 325 mg PO qd
- Cerebrovascular Accident
- Prevention in known vascular disease: 160-325 mg qd
- O'Connor (2001) Am J Cardiol 88:541-6
- Antipyretic or Analgesic Dose
- Adult: 600 mg PO q4 hours
- Adult: 650-1000 mg PO q4-6 hours
- Antiinflammatory dose
- Adult: 4 grams maximum per day
- Drug Interactions
- Ibuprofen inactivates Aspirin Anticoagulation effect
- Competes for same receptors
- Naprosyn and Indocin do not do this
- Effects
- Analgesic effect for mild to moderate pain at low dose
- Antiinflammatory effect at high dose
- Antipyretic effect
- Inhibition of platelet aggregation
- Irreversible platelet inhibition after single dose
- Effect lasts for the lifetime of platelet (8-10 days)
- Pharmacokinetics
- Duration: 4 hours
- Advantages
- Safer and lower cost than many NSAIDs
- Aspirin is an underused medication
- Adverse effects
- Gastrointestinal Effects
- Gastrointestinal intolerance
- Peptic Ulcer Disease (Erosive Gastritis)
- Aspirin higher risk for Peptic Ulcer Disease
- Other Salicylates have lower risk than most NSAIDs
- Gastrointestinal Bleeding
- Middle aged: 2-4 per 1000 on Aspirin 5 years
- Older patient: 4-12 per 1000 on Aspirin for 5 years
- Roderick (1993) Br J Clin Pharmacol 35:219-26
- Central Nervous System Effects: Salicylism
- Tinnitus
- Decreased hearing acuity
- Vertigo
- Central Respiratory effects
- Very high dose: Hyperpnea
- Lethal doses: Respiratory depression or apnea
- Miscellaneous Effects
- Serum Uric Acid changes
- Aspirin <2 g/day: increases serum Uric Acid
- Aspirin >4 g/day: lowers serum Uric Acid <2.5 mg/dl
- Asymptomatic hepatitis
- Exacerbation of renal insufficiency
- Hypersensitivity Reaction (Aspirin Allergy)
- Associated with Nasal Polyps and Asthma
- References
- McCarty (1972) Arthritis and Allied Conditions
- Katzung (1989) Basic and Clinical Pharmacology
- (2000) Med Lett Drugs Ther 42(1085):73-8